From summer lull to biotech's record-breaking month | Evaluate
Puma investors look for second lightning strike | Evaluate
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
Vir Biotech IPO: What You Need To Know
DFAN14A
Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
Puma Biotechnology - Crunchbase Company Profile & Funding
Why Puma Biotechnology Is Soaring Today | Nasdaq
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib | Nasdaq
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech to pay PPD founder $22M in defamation suit from proxy fight | Fierce Pharma
Puma Biotechnology
Alan Auerbach: Puma Biotech's Overnight Billionaire - Forbes India
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo
Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
